News
Sarepta Therapeutics (SRPT) stock drops as the company faces potential FDA-mandated studies after safety concerns over its ...
Authorities say rapper GloRilla was arrested on felony drug chargers after marijuana was found by deputies while they ...
Aging America may revive healthcare stocks after a rough year — discover why long-term trends point to a powerful rebound.
Mother-to-child transmission often led to pretreatment drug resistance and acquired drug resistance in children living with ...
AstraZeneca's gefurulimab showed clinical benefits and favorable safety in Phase 3 trial for adults with anti-AChR ...
Shares of Viking slide after Q2 loss widens to 58 cents per share on rising R&D and nil revenues, missing estimates by 14 cents.
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.
12h
Zacks Investment Research on MSNBristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?
Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...
An NHS surgeon has delivered his 'hot take' on why weight-loss jabs like Wegovy and Mounjaro are causing 'Ozempic babies' to be born.
13h
Zacks Investment Research on MSNHow Will Eli Lilly's Oncology Drugs Perform in Q2 Earnings?
Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company’s primary focus is ...
Verastem Oncology ( NASDAQ: VSTM) said that the U.S. FDA has granted fast track designation to its experimental drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results